TOLL FREE: 1.800.423.8211 > Dogs > Medications > Vaccines > Item # P00232

Bronchicine CAe 50x1ml VIals Canine Vaccine

Regularly: $404.39
Today's savings: 36%

Sometimes, manufacturers require that products be advertised only at their suggested prices. When we choose to sell these items for less, we display the sale price only in the cart. To see the price, click Add to Cart.

Bronchicine CAe 50x1ml VIals Canine Vaccine


In Stock. Usually Ships within 24 hours.

Shipping weight = 5.00 lbs.

Shipping Restrictions Apply: Must Ship 2 Day Service

Product Summary:

Bronchicine CAe  50 x 1 Canine Vaccine
The Bronchicine CAe  50 x 1 Canine Vaccine is approved for healthy dogs 8 weeks of age or older to help control canine infectious trachebronchitis (kennel cough) caused by Bordetella bronchiseptica.
  • Protects against Bordetella bronchiseptica, the primary pathogen in Canine Infectious Respiratory Disease (CIRD)
  • For healthy dogs 8 weeks of age or older
Item Specifications:
Please Note: This item is Non-Returnable and Non-Refundable.

Zoetis, Inc.
50 x 1 ds Tray
Active Ingredient:
Bordetella Bronchiseptica Bacterin, Cellular Antigen Extract
Directions for Use:
Injectable B. bronchiseptica vaccine.
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 2-4 weeks apart. Annual revaccination with a single dose is recommended.
The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to the bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica in dogs.
Store at 2°-7°C (35° to 45°F)
Prolonged exposure to higher temperatures may adversely affect potency.
Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine.
Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product.
As with many vaccines, anaphylaxis may occur after use.
Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
For additional Shipping and Product information please see clickable links listed under Downloadable Resources to the right. 
Downloadable Resources
Vaccine Shipping Information*IMPORTANT INFORMATION*
Product Label InformationManufacturer Information
MSDS SheetManufacturer Information
How To Prepare VaccinesPreparing Vaccines
Item Number Model Number UPC
P00232 003PFZ-3551 087219088708

Product Reviews by Customers

Start typing your question and we'll check if it was already asked and answered. Learn More
No questions have been asked about this item. Be the first!